title: Birth weight and other perinatal factors and childhood CNS tumors: a case-control study in California.
abstract: OBJECTIVE
  We conducted a large registry-based study in California to investigate the association of perinatal factors and childhood CNS tumors, with analysis by tumor subtype.
  
  
  METHODS
  We linked California cancer and birth registries to obtain information on 3308 cases and 3308 controls matched on age and sex. We examined the association of birth weight, gestational age, birth order, parental ages, maternal conditions during pregnancy, newborn abnormalities and the risk of childhood CNS tumors using conditional logistic regression, with adjustment for potential confounders.
  
  
  RESULTS
  The odds ratio (OR) per 1000 g increase in birth weight was 1.11 (95% CI: 0.99-1.24) for total childhood CNS tumors, 1.17 (95% CI: 0.97-1.42) for astrocytoma and 1.28 (95% CI: 0.90-1.83) for medulloblastoma. Compared to average-for-gestational age, large-for-gestational age infants were at increased risk of glioma (OR=1.86, 95% CI: 0.99-3.48), while small-for-gestational age infants were at increased risk of ependimoma (OR=2.64, 95% CI: 1.10-6.30). Increased risk of childhood CNS tumors was observed for 5-year increase in maternal and paternal ages (OR=1.06, 95% CI: 1.00-1.12 and 1.05, 95% CI: 1.00-1.10 respectively). Increased risk of astrocytoma was detected for 5-year increase in paternal age (OR=1.08; 95% CI: 1.00-1.16) and increased risk of glioma for maternal age ≥ 35 years old (OR=1.87; 95% CI: 1.00-3.52). Maternal genital herpes during pregnancy was associated with a pronounced increase in risk of total CNS tumors (OR=2.74; 95% CI: 1.16-6.51). Other (non-sexually transmitted) infections during pregnancy were associated with decreased risk of total CNS tumors (OR=0.28, 95% CI: 0.09-0.85). Maternal blood/immune disorders during pregnancy were linked to increased risk of CNS tumors (OR=2.28, 95% CI: 1.08-4.83) and medulloblastoma (OR=7.13, 95% CI: 0.82-61.03). Newborn CNS abnormalities were also associated with high risk of childhood CNS tumors (OR=4.08, 95% CI: 1.13-14.76).
  
  
  CONCLUSIONS
  Our results suggest that maternal genital herpes, blood and immunological disorders during pregnancy and newborn CNS abnormalities were associated with increased risk of CNS tumors. Maternal infections during pregnancy were associated with decreased risk of CNS tumors. Advanced maternal and paternal ages may be associated with a slightly increased risk of CNS tumors. Factors associated with CNS tumor subtypes varied by subtype, an indicator of different etiology for different subtypes.
authors.affiliation: Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. soksuzyan@ucla.edu
authors.forename: S
authors.initials: S
authors.lastname: Oksuzyan
authors.forename: C M
authors.initials: CM
authors.lastname: Crespi
authors.forename: M
authors.initials: M
authors.lastname: Cockburn
authors.forename: G
authors.initials: G
authors.lastname: Mezei
authors.forename: L
authors.initials: L
authors.lastname: Kheifets
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001724:Birth Weight; D002140:California / Q000453:epidemiology; D016022:Case-Control Studies; D002490:Central Nervous System / Q000002:abnormalities*; D016543:Central Nervous System Neoplasms / Q000453:epidemiology* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016015:Logistic Models; D008297:Male; D008423:Maternal Age; D010331:Paternal Age; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology* / Q000503:physiopathology; D012042:Registries; D012307:Risk Factors; D055815:Young Adult
references.citation: Cancer Causes Control. 1996 Jul;7(4):437-48
references.pmid: 8813432
references.citation: J Perinatol. 2005 Oct;25(10):631-7
references.pmid: 16107872
references.citation: Oncogene. 2003 Aug 11;22(33):5181-91
references.pmid: 12910255
references.citation: Int J Epidemiol. 2003 Apr;32(2):248-56
references.pmid: 12714545
references.citation: Am J Epidemiol. 2008 Aug 15;168(4):366-73
references.pmid: 18579539
references.citation: Int J Epidemiol. 2006 Dec;35(6):1495-503
references.pmid: 17008361
references.citation: Cancer Causes Control. 2001 Jun;12(5):443-9
references.pmid: 11545459
references.citation: Epidemiology. 2009 Jul;20(4):475-83
references.pmid: 19373093
references.citation: Am J Epidemiol. 2004 Jun 15;159(12):1109-16
references.pmid: 15191928
references.citation: Cancer Res. 1990 May 1;50(9):2608-12
references.pmid: 2328486
references.citation: Br J Cancer. 1999 Aug;80(11):1844-51
references.pmid: 10468308
references.citation: Stat Med. 1991 Apr;10(4):585-98
references.pmid: 2057657
references.citation: Cancer Res. 1982 Dec;42(12):5240-5
references.pmid: 7139628
references.citation: Paediatr Perinat Epidemiol. 1999 Jul;13(3):325-41
references.pmid: 10440052
references.citation: J Neurooncol. 1996 Sep;29(3):197-205
references.pmid: 8858525
references.citation: Cancer Causes Control. 2013 Feb;24(2):391-402
references.pmid: 23247637
references.citation: Int J Cancer. 1994 Dec 15;59(6):776-82
references.pmid: 7989118
references.citation: Obstet Gynecol. 1996 Feb;87(2):163-8
references.pmid: 8559516
references.citation: Cancer Causes Control. 2006 Dec;17(10):1267-74
references.pmid: 17111258
references.citation: Pediatrics. 1989 Sep;84(3):536-41
references.pmid: 2771556
references.citation: Epidemiology. 1999 May;10(3):271-5
references.pmid: 10230837
references.citation: Lancet Oncol. 2006 Jan;7(1):39-42
references.pmid: 16389182
references.citation: Int J Cancer. 1998 Aug 12;77(4):498-503
references.pmid: 9679748
references.citation: Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):127-33
references.pmid: 8850274
references.citation: Cancer Epidemiol. 2009 Nov;33(5):363-7
references.pmid: 19932649
references.citation: J Occup Environ Med. 1998 Apr;40(4):332-40
references.pmid: 9571524
references.citation: Pediatr Blood Cancer. 2010 Feb;54(2):242-9
references.pmid: 19813253
references.citation: Med Pediatr Oncol. 2001 Feb;36(2):274-82
references.pmid: 11452935
references.citation: Br J Cancer. 2002 Sep 23;87(7):746-50
references.pmid: 12232758
references.citation: Cancer Causes Control. 2001 Nov;12(9):865-74
references.pmid: 11714115
references.citation: Toxicol Appl Pharmacol. 2004 Sep 1;199(2):118-31
references.pmid: 15313584
references.citation: Eur J Neurol. 2005 Jul;12(7):508-13
references.pmid: 15958089
references.citation: Oncogene. 2003 Aug 11;22(33):5164-72
references.pmid: 12910253
references.citation: Cancer Detect Prev. 2008;32(1):79-86
references.pmid: 18396378
references.citation: Pediatrics. 2011 Sep;128(3):e652-7
references.pmid: 21824884
references.citation: Pediatrics. 1999 Aug;104(2):e18
references.pmid: 10429136
references.citation: J Clin Epidemiol. 1991;44(11):1159-66
references.pmid: 1941011
references.citation: J Natl Cancer Inst. 1962 Jan;28:231-44
references.pmid: 14468028
references.citation: Am J Public Health. 1998 May;88(5):813-6
references.pmid: 9585754